Nutriband Inc (NTRB) Peer Comparison
$4.55
$-0.07
(-1.60%)
As on 28-Aug-2026 16:00EDT
Market cap
$54 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
9.5
Div. Yield
0 %
Edit
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
54 | 2,543 | 655 | 33 | 14 |
Revenue ($ Mln) |
2 | 870 | 320 | 402 | -- |
Net Profit ($ Mln) |
-8.08 | -7.90 | -36.74 | -49.19 | -9.14 |
Net Margin (%) |
-448.39 | -0.91 | -11.48 | -12.24 | -10.21 |
RoE (%) |
-119.40 | -0.38 | -20.77 | -80.08 | -8.10 |
Price to Earnings |
-- | -- | -- | -- | -- |
Price-To-Book |
9.50 | 1.22 | 3.82 | 0.75 | 62.84 |
Income Statement ($ Mln)
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2.04 | 870.40 | 320.17 | 401.95 | 0.00 |
|
Cost of Revenue
|
1.47 | 461.90 | 145.28 | 290.49 | 0.13 |
|
Gross Profit
|
0.57 | 408.50 | 174.89 | 111.45 | -0.13 |
|
Operating Expenses
|
8.88 | 430.10 | 214.82 | 137.90 | 8.28 |
|
Operating Profit (EBIT)
|
-8.32 | -21.60 | -39.93 | -26.44 | -8.41 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-8.23 | -9.00 | -36.30 | -47.25 | -9.14 |
|
Provision for Tax
|
-- | -1.10 | 0.44 | 1.95 | -3.68 |
|
Profit after Tax (Net Income)
|
-8.23 | -7.90 | -36.74 | -49.19 | -9.14 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6.68 | 2,092.90 | 170.83 | 41.70 | 225.53 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
0.08 | 1,094.90 | 21.62 | 210.57 | 175.50 |
|
Current Liabilities
|
0.78 | 158.20 | 74.72 | 191.41 | 4,861.11 |
|
Total Liabilities
|
7.55 | 3,346.00 | 267.16 | 443.68 | 5,262.67 |
Assets ($ Mln)
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
2.56 | 2,741.40 | 103.77 | 156.18 | 2,679.75 |
|
Current Assets
|
4.99 | 604.60 | 163.39 | 287.50 | 2,582.93 |
|
Total Assets
|
7.55 | 3,346.00 | 267.16 | 443.68 | 5,262.14 |
|
Total Debt*
|
0.25 | 793.70 | 10.15 | 183.87 | 3,936.65 |
|
Net Current Assets
|
4.20 | 446.40 | 88.68 | 124.89 | -2.28 |
Cashflow ($ Mln)
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-5.13 | 83.20 | 3.09 | -6.98 | -7.43 |
|
Cash Flow from Investing Activities
|
-0.01 | 70.50 | -5.95 | -12.28 | -0.04 |
|
Cash from Financing Activities
|
5.40 | -99.40 | 0.56 | 6.98 | 8.03 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-121.56 | -0.27 | -20.19 | -20.37 | -0.44 |
|
ROE (%)
|
-125.56 | -0.38 | -20.77 | -80.08 | -8.10 |
|
ROA (%)
|
-109.60 | -0.23 | -13.43 | -10.77 | -0.35 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-404.08 | -0.91 | -11.48 | -12.24 | -211,666.47 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.05 | -0.03 | 0.09 | -0.12 | -0.01 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
21.50 | 99.28 | -8.09 | -2,992.02 | -4.30 |
|
EPS Growth (%)
|
-- | -- | -- | -26.45 | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -0.64 | -- |
|
Price / Book Value
|
-- | -- | -- | 0.76 | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.54 | 3.57 | -286.51 | -12.15 | -270.99 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.04 | 0.38 | 0.06 | 4.41 | 17.46 |
|
Short term debt to equity ratio
|
0.02 | 0.01 | 0.01 | 0.23 | 16.68 |
|
Current Ratio
|
6.36 | 3.82 | 2.19 | 1.50 | 0.53 |
|
Quick Ratio
|
6.21 | 2.91 | 1.49 | 0.73 | 0.40 |
|
Interest Coverage
|
-364.19 | 0.84 | -75.14 | 1.09 | -21.72 |
Operating Efficiency Ratios
| Nutriband Inc (NTRB) | Neogen (NEOG) | AngioDynamics (ANGO) | Accuray (ARAY) | Heart Test Laboratories Inc. (HSCS) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
5.81 | 16.87 | 15.09 | 16.77 | 0.00 |
|
Asset Turnover
|
0.27 | 0.26 | 1.17 | 0.88 | 0.00 |
|
Receivable days
|
17.24 | 62.98 | 52.17 | 75.09 | 183.94 |
|
Inventory Days
|
40.99 | 132.51 | 143.86 | 181.12 | 900,351.58 |
|
Payable days
|
149.23 | 62.75 | 81.46 | 46.89 | 437,150.98 |
|
Cash Conversion Cycle
|
-91.00 | 132.75 | 114.57 | 209.32 | 463,384.53 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
